MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...
A member of the U.K. Parliament is calling for regulators to audit pharmaceutical companies that have made misleading ...
Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...
Moderna’s norovirus vaccine trial placed on FDA hold over reported case of Guillain-Barré syndrome
A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological ...
Moderna Inc. recorded a quarterly loss as vaccine sales waned and the company had an unexpected charge for a canceled ...
Pfizer’s contributions to animal health date back several decades, during which the company played a significant role in ...
Ten months after Pfizer scored approval in Europe for Emblaveo (aztreonam and avibactam) to treat complicated intra-abdominal infections (cIAIs), AbbVie has done the same in the U.S., ...
Vaccines are designed to guard babies, toddlers, and older children against a whole range of serious and potentially deadly ...
IFLScience on MSN4d
Montana Considers Becoming First US State To Ban mRNA Vaccine UseLaura is an editor and staff writer at IFLScience. She obtained her Master's in Experimental Neuroscience from Imperial College London.
Texas Attorney General Ken Paxton has launched an investigation into DeepSeek, the upstart Chinese artificial intelligence ...
The Senate officially confirmed Robert F. Kennedy Jr.'s nomination as secretary of Health and Human Services on Thursday. The final vote count was 52 in favor and 48 against, with Sen. Mitch McConnell ...
Moderna (MRNA), once a pandemic-era darling, has seen its stock plummet 65% over the past year, battered by fading vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback